Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessy Presumey

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Advances in Immunology|August 23, 2017
Complement System in Neural Synapse Elimination in Development and DiseaseJessy Presumey, Allison R Bialas, Michael C Carroll
Current Opinion in Molecular Therapeutics|June 4, 2010
Cationic liposome formulations for RNAi-based validation of therapeutic targets in rheumatoid arthritisJessy Presumey, Isabelle Duroux-Richard, Gabriel Courties, et al.
Expert Opinion on Biological Therapy|April 28, 2009
RNA interference-based gene therapy for successful treatment of rheumatoid arthritisGabriel Courties, Jessy Presumey, Isabelle Duroux-Richard, et al.
Genome Research|February 3, 2017
microRNA target prediction programs predict many false positivesNatalia Pinzón, Blaise Li, Laura Martinez, et al.
Cells|February 25, 2025
In Vitro Evaluation of Genetically Unmodified Ligand-Armed Allogeneic Natural Killer Cells to Treat EGFR-Positive GlioblastomaHortense Courot, Emilie Rigal, Nawfel Adib, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2015
Inhibition of Inflammation and Bone Erosion by RNA Interference-Mediated Silencing of Heterogeneous Nuclear RNP A2/B1 in Two Experimental Models of Rheumatoid ArthritisSonja Herman, Anita Fischer, Jessy Presumey, et al.
Joint Bone Spine|September 25, 2010
MicroRNAs as new player in rheumatoid arthritisIsabelle Duroux-Richard, Jessy Presumey, Gabriel Courties, et al.
Cell Reports|November 4, 2020
Complement C4A Regulates Autoreactive B Cells in Murine LupusLéa Simoni, Jessy Presumey, Cees E van der Poel, et al.
Nature Neuroscience|December 23, 2020
Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in miceMelis Yilmaz, Esra Yalcin, Jessy Presumey, et al.
Oncoimmunology|August 23, 2024
<i>FCGR3A</i> F158V alleles frequency differs in multiple myeloma patients from healthy populationMichaël Constantinides, Nicolas Robert, Caroline Multrier, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Advances in Immunology|August 23, 2017
Complement System in Neural Synapse Elimination in Development and DiseaseJessy Presumey, Allison R Bialas, Michael C Carroll
Current Opinion in Molecular Therapeutics|June 4, 2010
Cationic liposome formulations for RNAi-based validation of therapeutic targets in rheumatoid arthritisJessy Presumey, Isabelle Duroux-Richard, Gabriel Courties, et al.
Expert Opinion on Biological Therapy|April 28, 2009
RNA interference-based gene therapy for successful treatment of rheumatoid arthritisGabriel Courties, Jessy Presumey, Isabelle Duroux-Richard, et al.
Genome Research|February 3, 2017
microRNA target prediction programs predict many false positivesNatalia Pinzón, Blaise Li, Laura Martinez, et al.
Cells|February 25, 2025
In Vitro Evaluation of Genetically Unmodified Ligand-Armed Allogeneic Natural Killer Cells to Treat EGFR-Positive GlioblastomaHortense Courot, Emilie Rigal, Nawfel Adib, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 29, 2015
Inhibition of Inflammation and Bone Erosion by RNA Interference-Mediated Silencing of Heterogeneous Nuclear RNP A2/B1 in Two Experimental Models of Rheumatoid ArthritisSonja Herman, Anita Fischer, Jessy Presumey, et al.
Joint Bone Spine|September 25, 2010
MicroRNAs as new player in rheumatoid arthritisIsabelle Duroux-Richard, Jessy Presumey, Gabriel Courties, et al.
Cell Reports|November 4, 2020
Complement C4A Regulates Autoreactive B Cells in Murine LupusLéa Simoni, Jessy Presumey, Cees E van der Poel, et al.
Nature Neuroscience|December 23, 2020
Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in miceMelis Yilmaz, Esra Yalcin, Jessy Presumey, et al.
Oncoimmunology|August 23, 2024
<i>FCGR3A</i> F158V alleles frequency differs in multiple myeloma patients from healthy populationMichaël Constantinides, Nicolas Robert, Caroline Multrier, et al.
Pageof 2